EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antineoplastic drugs inducing cardiac and vascular toxicity – An update

Serena Barachini, Sandra Ghelardoni, Zoltán V Varga, Radwa A Mehanna, Maria Magdalena Montt-Guevara, Péter Ferdinandy, Rosalinda Madonna

Vascular Pharmacology · 2023-12 · 153 · 107223

DOI: 10.1016/j.vph.2023.107223 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2023-12. Verfasst von Serena Barachini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Laboratory for Cell Therapy, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Antineoplastic Agents, Heart Diseases, Heart Failure, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the improvement in cancer prognosis due to advances in antitumor therapeutic protocols and new targeted and immunotherapies, we are witnessing a growing increase in survival, however, at the same timeincrease in morbidity among cancer survivors as a consequences of the increased cardiovascular adverse effects of antineoplastic drugs. Common cardiovascular complications of antineoplastic therapies may include cardiac complications such as arrhythmias, myocardial ischemia, left ventricular dysfunction culminating in heart failure as well as vascular complications including arterial hypertension, thromboembolic events, and accelerated atherosclerosis. The toxicity results from the fact that these drugs not only target cancer cells but also affect normal cells within the cardiovascular system. In this article, we review the clinical features and main mechanisms implicated in antineoplastic drug-induced cardiovascular toxicity, including oxidative stress, inflammation, immunothrombosis and growth factors-induced signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsHeart DiseasesHeart FailureNeoplasmsHumansCardiotoxicityHeart

Stichwörter der Autor:innen

AntimetabolitesCardio-oncology, immune checkpoint inhibitors, anthracyclinesCardiotoxicityHER2Microtubule inhibitorsPlatinumProteasome inhibitorsTyrosine kinase inhibitorsVascular toxicity

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, Laboratory for Cell Therapy, University of Pisa, Pisa, Italy.
  • Department of Pathology, Laboratory of Biochemistry, University of Pisa, Pisa, Italy.
  • Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; HCEMM-SU Cardiometabolic Immunology Research Group, Budapest, Hungary; MTA-SE Momentum Cardio-Oncology and Cardioimmunology Resea…
  • Medical Physiology Department, Center of Excellence for Research in Regenerative Medicine and Applications (CERRMA), Faculty of Medicine, Alexandria University, Egypt.
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; Pharmahungary Group, Szeged, Hungary.

Zitieren

APA

Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., Montt-Guevara, M. M., Ferdinandy, P., & Madonna, R. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity – An update. Vascular Pharmacology, 153, 107223. https://doi.org/10.1016/j.vph.2023.107223

Vancouver

Barachini S, Ghelardoni S, Varga ZV, Mehanna RA, Montt-Guevara MM, Ferdinandy P, et al. Antineoplastic drugs inducing cardiac and vascular toxicity – An update. Vascular Pharmacology. 2023;153:107223. doi:10.1016/j.vph.2023.107223

BibTeX
@article{Barachini2023,
  author = {Barachini, Serena and Ghelardoni, Sandra and Varga, Zoltán V and Mehanna, Radwa A and Montt-Guevara, Maria Magdalena and Ferdinandy, Péter and Madonna, Rosalinda},
  title = {Antineoplastic drugs inducing cardiac and vascular toxicity – An update},
  journal = {Vascular Pharmacology},
  year = {2023},
  volume = {153},
  pages = {107223},
  doi = {10.1016/j.vph.2023.107223}
}
Kostenlos starten →